NELSON MULLINS RILEY & SCARBOROUGH

Lobbying for PHRMA · Pharmaceutical

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $30,000.00 income · posted Jan 20, 2026

Lobbying activity 2

Health Issues

Work to protect patent protections for pharmaceutical companies and other general issues relating to the Pharmaceutical Industry

Medicare/Medicaid

Work to protect patent protections for pharmaceutical companies and other general issues relating to the Pharmaceutical Industry, Medicare Part B

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.